A previously healthy 26-year-old woman presented to her gynecologist with painful swelling of both breasts. Suspected diagnosis was fibrocystic mastopathy (Fig. 1a). As petechial bleeding of the lower extremities was found during physical examination, she was admitted to the hospital for evaluation. Laboratory test results included thrombocytopenia and leukocytosis of 212,700/µl. Flow cytometry analysis uncovered cortical acute T-lymphoblastic leukemia (T-ALL). Computed tomography of the chest revealed a large, anterior mediastinal mass measuring 9.2 × 9.3 × 13.2 cm (a common finding in T-ALL) and leukemic infiltrates of both breasts (Fig. 1b). Cytomorphology confirmed the presence of lymphatic blasts (Fig. 1c). The patient received chemotherapy containing dexamethasone and cyclophosphamide with substantial improvement in her symptoms (Fig. 1d). A follow-up CT scan revealed disappearance of leukemic infiltrates and a marked decrease in the size of the mediastinal mass (Fig. 1e).
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.